Search
for
Sort by
Research 331–360 of 1000+
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
- Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS
- Cutaneous Manifestations in Patients with Polycystic Ovary Syndrome: Their Prevalence and Correlation with Hormonal and Metabolic Parameters
- Dermatologic manifestations in patients with polycystic ovary syndrome: their prevalence and assessment in relation to hormonal and metabolic changes
- Integrative Nutritional Mechanisms of Keyora Lycopene 23 in 1 Man's Multi-Vitamin in Erectile Dysfunction, Male Infertility, Prostatic Disorders, and Metabolic Dysregulation
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior
- Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
- Adult polycystic ovary syndrome begins in childhood
- 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation
- Everything you want to know about androgens
- Polycystic Ovary Syndrome: Pathophysiology, Presentation and Treatment a Mini-Review Article
- Molecular mechanisms of androgenetic alopecia
- Diagnosis of hyperandrogenism: Biochemical criteria
- Testosterone, cytochrome P450, and cardiac hypertrophy
- Androgen Profiling by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Trace elements content and hormonal profiles in women with androgenetic alopecia
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Rational investigations in the diagnosis and management of women with hirsutism or androgenetic alopecia
- Management of Polycystic Ovarian Syndrome: Looking Beyond the Ovaries
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Effect of Carbamates on mRNA Encoding Lipid Enzymes in Hamster Flank Organs
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study